Friday, September 22, 2017
 
 
Company News: Page (1) of 1 - 09/12/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global Nitric Oxide Therapeutics, Markets and Companies Research Report 2017
 
(September 12, 2017)

DUBLIN, September 12, 2017 /PRNewswire/ --

The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to Research and Markets' offering.

Research and Markets Logo

This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric oxide-based drugs are described as well as the companies involved in developing them.


Important therapeutic areas for NO-based therapies are inflammatory disorders, cardiovascular diseases, erectile dysfunction, inflammation, pain and neuroprotection. The first therapeutic use of NO was by inhaltion for acute respiratory distress syndrome (ARDS). NO-donors, NO-mimics and NOS modulators are described and compared along with developmental status. NO-related mechanisms of action in existing drugs are identified.

Various pharmacological approaches are described along with their therapeutic relevance. Various approaches are compared using SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis. NO-based therapies are compared with conventional approaches and opportunities for combination with modern biotechnology approaches are described.

Share of drugs where NO is involved in the mechanism of action is analyzed in the worldwide pharmaceutical market for 2016 and is projected to 2021 and 2026 as new drugs with NO-based mechanisms are introduced into the market. Various strategies for developing such drugs are discussed.

Key Topics Covered:

Executive Summary

1. Introduction

2. Nitric Oxide Pathways

3. Role of NO in Physiology

4. Role of NO in Diseases

5. Pharmacology of Nitric Oxide

6. Therapeutic Applications

7. Evaluation of NO-Based Drugs

8. Markets for NO-based Therapies

9. Companies

10. References

For more information about this report visit https://www.researchandmarkets.com/research/nwvpqx/nitric_oxide

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-nitric-oxide-therapeutics-markets-and-companies-research-report-2017-300517829.html

SOURCE Research and Markets

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Medicine, Disease, medical technologists, Surgery, Medication, Mens Health, Science, Medical,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines